We handhold our clients through product development to address unmet medical needs in the following areas
Psychiatry | Respiratory | Diabetology | Oncology
PR/SR formulations | Inhalation systems | novel delivery platforms
Designs pre-validated for USFDA, EMA, ANVISA, and WHO markets
Competitive Landscape Mapping:
Map RLD features; monitor clinical, regulatory, and supply indicators to anticipate competitor moves and entry risk.
Therapeutic Gap Identification:
Prioritize markets with <3 generic competitors and>$250M brand sales
Data-Driven Decision Making for Complex Generics
Global innovators choose us to convert R&D spend into faster, de‑risked outcomes. Our resource‑optimized, model‑informed approach front‑loads in‑silico PBPK/IVIVC/VBE analyses, streamlines protocols, and prioritizes high‑value studies. Deep complex‑generics expertise and transparent governance compress timelines, lower costs, and deliver decision‑grade evidence—from pilot insights to pivotal designs—for confident, product‑centric advancement at scale
15+ years in complex generics; experience across 87 commercialized programs since 2015.
Pre‑vetted CROs, API suppliers, and regulatory specialists across US/EU/India.
Phase‑appropriate development models that stage investment, de‑risk pivots, and cut CAPEX via virtual assessments.
KAAS BioPharma: Accelerating pharmaceutical innovation through GenAI-powered predictive modeling, strategic clinical development, regulatory excellence, and global partnership for impactful product development.
A 410, Shelton Sapphire, Plot no 18 & 19, Sector 15, CBD Belapur, Navi Mumbai, Maharashtra 400614
